BioPharmX to Report Fourth Quarter and Full Year Financial Results on April 26, 2016

MENLO PARK, Calif., April 13, 2016 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company focusing on dermatology and women's health, today announced that it will release its financial results for the fiscal fourth quarter and full year ended January 31, 2016 after the close of trading on Tuesday, April 26, 2016. The company's management team will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET to discuss the financial results and recent business developments.

Individuals interested in listening to the conference call may do so by dialing (866) 250-8117 for domestic callers or (412) 317-6011 for international callers, and request to join the BioPharmX Corporation call. To listen to a live webcast, please visit the investor relations section of the BioPharmX website at: www.BioPharmX.com.  

A replay of the call will be available beginning April 26, 2016 at 4:30pm PT/7:30pm ET through midnight ET on April 27, 2016. To access the replay, dial (877) 344-7529 or (412) 317-0088 and reference Conference ID: 10083618. The webcast will also be available on the BioPharmX website for 90 days following the completion of the call.

About BioPharmX^® Corporation
BioPharmX Corporation (NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through proprietary platform technologies for prescription, over-the-counter (OTC), and supplement applications in the health and wellness markets, including dermatology and women's health. To learn more about BioPharmX, visit www.BioPharmX.com.

Logo - http://photos.prnewswire.com/prnh/20150711/235327LOGO

SOURCE BioPharmX Corporation

Related Links

http://www.BioPharmX.com